[go: up one dir, main page]

GB201408171D0 - Formulation and method of manufacture - Google Patents

Formulation and method of manufacture

Info

Publication number
GB201408171D0
GB201408171D0 GBGB1408171.5A GB201408171A GB201408171D0 GB 201408171 D0 GB201408171 D0 GB 201408171D0 GB 201408171 A GB201408171 A GB 201408171A GB 201408171 D0 GB201408171 D0 GB 201408171D0
Authority
GB
United Kingdom
Prior art keywords
formulation
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1408171.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aimsco Ltd
Original Assignee
Aimsco Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aimsco Ltd filed Critical Aimsco Ltd
Priority to GBGB1408171.5A priority Critical patent/GB201408171D0/en
Publication of GB201408171D0 publication Critical patent/GB201408171D0/en
Priority to PCT/GB2015/051369 priority patent/WO2015170122A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1408171.5A 2014-05-08 2014-05-08 Formulation and method of manufacture Ceased GB201408171D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1408171.5A GB201408171D0 (en) 2014-05-08 2014-05-08 Formulation and method of manufacture
PCT/GB2015/051369 WO2015170122A1 (en) 2014-05-08 2015-05-08 Formulation and method of manufacture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1408171.5A GB201408171D0 (en) 2014-05-08 2014-05-08 Formulation and method of manufacture

Publications (1)

Publication Number Publication Date
GB201408171D0 true GB201408171D0 (en) 2014-06-25

Family

ID=51032449

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1408171.5A Ceased GB201408171D0 (en) 2014-05-08 2014-05-08 Formulation and method of manufacture

Country Status (2)

Country Link
GB (1) GB201408171D0 (en)
WO (1) WO2015170122A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201501800D0 (en) * 2015-02-03 2015-03-18 Aimsco Ltd Treatment of medical conditions
GB201911063D0 (en) * 2019-08-02 2019-09-18 Tarian Biologics Ltd Formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2337795T3 (en) * 2003-12-11 2010-04-29 Aimsco Limited USE OF GOAT SERUM FOR VETERINARY TREATMENT.
GB0415359D0 (en) * 2004-07-08 2004-08-11 Aimsco Ltd Medicament
GB0509052D0 (en) * 2005-05-04 2005-06-08 Aimsco Ltd Combination therapy
WO2014001749A1 (en) * 2012-06-25 2014-01-03 Aimsco Limited Formulation comprising crh and alpha - 2 - immunoglobulin
US20130344102A1 (en) * 2012-06-25 2013-12-26 Aimsco Limited Formulation

Also Published As

Publication number Publication date
WO2015170122A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
IL250415B (en) Anti-pdl- antibodies and methods of use thereof
GB2526633B (en) Garment and method of manufacturing same
SG11201606575TA (en) Method of producing polyethylene and polyethylene thereof
GB201514756D0 (en) Compound and method of use
HUE061672T2 (en) Glycan-interacting compounds and methods of use
PL3089971T3 (en) Compounds and methods of use
GB201514760D0 (en) Compounds and method of use
GB201421894D0 (en) End fitting and method of manufacture
EP3099493A4 (en) Printbars and methods of forming printbars
GB2522719B (en) Method of manufacture
IL249348A0 (en) Novel formulation and method of synthesis
IL249662A0 (en) Tampon and method of making
GB2544343B (en) Receptacle and its method of manufacture
PL3127605T3 (en) Method of manufacturing packing and packing
ZA201606450B (en) Compounds and their methods of use
TWI563577B (en) Package structure and method of manufacture
TWI563617B (en) Substrate structure and method of manufacture
GB2522716B (en) Method of manufacture
GB201408171D0 (en) Formulation and method of manufacture
IL248035A0 (en) Database and method of use thereof
PT3227079T (en) Method of manufacture of an insulator and insulator
PL3084792T3 (en) Screw and method of its manufacture
GB201520479D0 (en) Turbulance-generating gris and method of manufacture
GB201403697D0 (en) Compounds and methods of use
GB201419990D0 (en) Hprseshoe and method of manufacture

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)